Krystal Biotech Files 8-K for Regulation FD Disclosure
Ticker: KRYS · Form: 8-K · Filed: May 13, 2025 · CIK: 1711279
| Field | Detail |
|---|---|
| Company | Krystal Biotech, Inc. (KRYS) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
TL;DR
Krystal Biotech dropped an 8-K on May 13th for a May 12th Reg FD disclosure. Details TBD.
AI Summary
Krystal Biotech, Inc. filed an 8-K on May 13, 2025, reporting an event on May 12, 2025. The filing is a Regulation FD Disclosure, indicating a public announcement or disclosure of material information. Specific details of the disclosure are not provided in the excerpt.
Why It Matters
This filing signals that Krystal Biotech has made a public disclosure of material information, which could impact investors' understanding of the company's status or future prospects.
Risk Assessment
Risk Level: medium — Regulation FD disclosures can cover a wide range of material information, and without knowing the specifics, it's impossible to assess the immediate risk.
Key Players & Entities
- Krystal Biotech, Inc. (company) — Registrant
- May 12, 2025 (date) — Earliest event date
- May 13, 2025 (date) — Filing date
- Regulation FD (regulation) — Disclosure type
FAQ
What specific information was disclosed under Regulation FD by Krystal Biotech on May 12, 2025?
The provided excerpt does not contain the specific details of the Regulation FD disclosure made by Krystal Biotech, Inc. on May 12, 2025.
What is the significance of a Regulation FD disclosure?
A Regulation FD disclosure ensures that material information is broadly disseminated to the public, preventing selective disclosure to certain investors or analysts.
When was this 8-K filing submitted to the SEC?
The 8-K filing was submitted to the SEC on May 13, 2025.
What is Krystal Biotech, Inc.'s principal executive office address?
Krystal Biotech, Inc.'s principal executive offices are located at 2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania 15203.
What is Krystal Biotech, Inc.'s standard industrial classification?
Krystal Biotech, Inc.'s standard industrial classification is BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding Krystal Biotech, Inc. (KRYS).